CHU Sainte-Justine Hospital in Quebec is leading a national research project investigating the effectiveness of using antibodies to treat infected patients.
Unprecedented times call for unprecedented solutions. To help fight COVID-19, we’re donating $500,000 to help develop and test a treatment using the antibodies of people who have recovered from the virus.
The national research project is being led by CHU Sainte-Justine Hospital, in collaboration with other leading hospitals and research institutions across Canada, including The Hospital for Sick Children, Sunnybrook Health Sciences Centre and McMaster University.
Recent studies have found that using the antibodies in blood plasma of people who have recovered from the virus has reduced the mortality risk of infected patients by up to 75 per cent.
CHU Sainte-Justine is a leader in the treatment of infectious diseases and precision medicine. With their expertise, the potential impact of this research could be a game changer on a global scale and put Canada at the forefront of the fight against this pandemic.
Helping our communities
At the onset of the pandemic, we focused our efforts on supporting the immediate needs of our customers and communities to help them be more resilient during this challenging time. That included financial relief efforts for customers and $3.5 million in donations to target the immediate needs of individuals and families who are most vulnerable to the social, health and economic effects of this pandemic.
Now it’s time to shift our focus to also address medium- and long-term needs and solutions. We have a long history of working with CHU Saint-Justine and supporting their efforts to provide leading edge health care to children in Quebec. We are honoured to be part of this important new initiative.
Return to all Press Releases